Status:
COMPLETED
Genetic Analysis of Psoriasis and Psoriatic Arthritis
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Psoriasis
Eligibility:
All Genders
1+ years
Brief Summary
This study will examine the genetic basis of psoriasis and psoriatic arthritis. It is known that genes play an important role in determining who gets psoriasis or psoriatic arthritis. This study will ...
Detailed Description
The aim of the study is to examine the role of HLA and killer immunoglobulin-like receptors (KIR) in the natural history of psoriasis vulgaris. Psoriasis is a chronic inflammatory disease of the skin ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- DNA and relevant clinical data from properly consented subjects will be provided to the LGD for genotyping and analysis. No available subjects will be excluded.
Exclusion
Key Trial Info
Start Date :
July 30 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 4 2012
Estimated Enrollment :
2653 Patients enrolled
Trial Details
Trial ID
NCT00341809
Start Date
July 30 2004
End Date
September 4 2012
Last Update
April 5 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48109-0624